# The involvement of TNFRSF25 in age-related hearing loss

**Authors:** Marie Valerie Roche, Pei-Ciao Tang, Denise Yan, Michelle Rose De Marchena, Maria Camila Robayo, Clemer Abad, Yan Guo, Feng Gong, Katherina Walz, Xue Zhong Liu

PMC · DOI: 10.1007/s00439-026-02826-5 · 2026-03-26

## TL;DR

This study identifies TNFRSF25 as a gene linked to age-related hearing loss through epigenetic changes and hair cell degeneration.

## Contribution

The study reveals a novel role of TNFRSF25 in hearing maintenance and age-related hearing loss through epigenetic and genetic evidence.

## Key findings

- A specific CpG site methylation near TNFRSF25 correlates with impaired hearing in ARHL patients.
- Mice lacking Tnfrsf25 exhibit severe hair cell depletion and nerve fiber degeneration.
- These findings suggest TNFRSF25 is crucial for maintaining hearing function.

## Abstract

Hearing loss is a prevalent sensory condition that affects the ability to perceive sounds. Hair cells play a vital role in hearing by converting mechanical sound vibrations into electrical signals that are transmitted to the brain. In humans, if damaged, these specialized sensory cells do not regenerate, leading to reduced sensitivity to sound, difficulty understanding speech, and deafness. The incidence of hearing loss increases with age, but it can also occur earlier due to genetic predisposition or environmental factors such as exposure to noise or ototoxic medications. Epigenetic mechanisms play a significant role in age-related hearing loss (ARHL) by regulating gene expression without changing the underlying DNA sequence. Aberrant DNA methylation patterns have been linked to ARHL. In this study, by performing an epigenome-wide association study in a cohort of 30 ARHL patients, we found a correlation between a specific CpG site methylation level proximal to the TNFRSF25 gene, with an impaired hearing threshold. Interestingly, Tnfrsf25 absence in mice cause ARHL, severe hair cell depletion, and degeneration of nerve fibers. Taking together these results suggests a crucial role of Tnfrsf25 expression in hearing maintenance.

The online version contains supplementary material available at 10.1007/s00439-026-02826-5.

## Linked entities

- **Genes:** TNFRSF25 (TNF receptor superfamily member 25) [NCBI Gene 8718], TNFRSF25 (TNF receptor superfamily member 25) [NCBI Gene 8718]
- **Diseases:** hearing loss (MONDO:0005365)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Myo7a (myosin VIIA) [NCBI Gene 17921] {aka Hdb, Myo7, USH1B, nmf371, polka, sh-1}, TNFRSF25 (TNF receptor superfamily member 25) [NCBI Gene 8718] {aka APO-3, DDR3, DR3, LARD, TNFRSF12, TR3}, Brd4 (bromodomain containing 4) [NCBI Gene 57261] {aka Brd5, HUNK1, MCAP, WI-11513}, Dnmt3b (DNA methyltransferase 3B) [NCBI Gene 13436] {aka MmuIIIB}, Tnfrsf1a (tumor necrosis factor receptor superfamily, member 1a) [NCBI Gene 21937] {aka CD120a, FPF, TNF-R, TNF-R-I, TNF-R1, TNF-R55}, Dner (delta/notch-like EGF repeat containing) [NCBI Gene 227325] {aka A930026D19Rik, BET, Bret}, Tnfrsf25 (tumor necrosis factor receptor superfamily, member 25) [NCBI Gene 85030] {aka APO-3, DDR3, DR3, LARD, TR3, TRAMP}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Nefh (neurofilament, heavy polypeptide) [NCBI Gene 380684] {aka NF-H, NF200, Nfh, mKIAA0845}, Espn (espin) [NCBI Gene 56226] {aka je}, Dnmt1 (DNA methyltransferase 1) [NCBI Gene 13433] {aka Cxxc9, Dnmt, Dnmt1o, MCMT, MTase, Met-1}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Dnmt3a (DNA methyltransferase 3A) [NCBI Gene 13435] {aka MmuIIIA}
- **Diseases:** Meniere's disease (MESH:D008575), dementia (MESH:D003704), hereditary sensory neuropathy (MESH:D009477), sensorineural hearing loss (MESH:D006319), deafness (MESH:D003638), bone trauma (MESH:D001847), presbycusis (MESH:D011304), cancers (MESH:D009369), HL (MESH:C538324), illness (MESH:D002908), blindness from retinitis pigmentosa (MESH:D012174), inner ear disorders (MESH:D007759), cochlear damage (MESH:D015834), neurological disorders (MESH:D009461), cardiovascular disease (MESH:D002318), ARHL (MESH:D010024), ear diseases (MESH:D004427), developmental defects (MESH:D000094602), tinnitus (MESH:D014012), tegumentary and craniofacial anomalies (MESH:D019465), neurodegeneration (MESH:D019636), inflammation (MESH:D007249), Hearing loss (MESH:D034381), degeneration of (MESH:D009410), conductive hearing loss (MESH:D006314), diabetes (MESH:D003920), auditory disorders (MESH:D006311)
- **Chemicals:** xylazine (MESH:D014991), A323931 (-), H (MESH:D006859), PBS (MESH:D007854), chloroform (MESH:D002725), ATP (MESH:D000255), DAPI (MESH:C007293), PFA (MESH:C003043), Alexa Fluor 488 (MESH:C000711379), TRIzol (MESH:C411644)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Gallus gallus (bantam, species) [taxon 9031]
- **Cell lines:** hg38 — Rattus norvegicus (Rat), Hybridoma (CVCL_A6AY), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018069/full.md

---
Source: https://tomesphere.com/paper/PMC13018069